|
Post by joeypotsandpans on Oct 23, 2017 15:21:22 GMT -5
Reality check, you don't need to start new threads every other day with the same messages and FUD, you can keep one thread and just repeat your sentiment.... you came on here in Jan 2014 with your first post on ORMP when it was at its peak and where is that now compared to then? FWIW, that's not actually true. Orlon might be perpetually negative and maybe even a MNKD short, but his first posts were in 2013 and were not about ORMP. His 2014 post about ORMP was just acknowledging that an analyst / blogger who covered both ORMP and MNKD had just made a good call at the time, contrary to what orlon's expectations were. But, really, why harp on orlon anyway when a majority of the posters here do the same thing (new threads with basically the same perpetually sunny scenarios). His first post on ORMP was with it being at it's peak, it was pretty much all downhill from there regarding their share price (albeit off the lows but still a far cry from the peak), that was my point....he was referencing/bringing up a company and someone that was critical of MNKD (De Stefano), my point was where have they been and where are they now? when he brought them up the price was approx $29/sh and currently sitting between $10-$11/sh. Regarding threads, there are those that are creatures of habit/lazy on both sides of the coin starting threads whether positive or negative...but when one says the same thing repetitively on one subject (which btw everyone both long and short know already regarding scripts/sales) it gets redundant. But hey thanks for checking up on this as someone that is just "hanging around" as you stated: 10 million share stock offering Oct 11, 2017 at 11:18am afrezzamiracle likes this Quote like Post Options Post by mnkdfann on Oct 11, 2017 at 11:18am One of my investments is MU. I've no MNKD shares presently, but I obviously follow it.
Last night both MNKD and MU announced share offerings. It is interesting how the corresponding (especially retail) investor groups viewed the offerings. MU investors were outraged, predicted a massive hit in MU's share price today. MNKD investors (judging from most comments here) were pleased as punch and predicting a restless night for, and the quick demise, of shorts. I found the different perspectives interesting, and funny (not in the humorous sense) how things turn out (MU is doing fine, and just might hit another 52-week high today). Read more: mnkd.proboards.com/user/2050/recent#ixzz4wMXTgGIbBottom line, we ALL know that scripts/sales need to increase at some point in time but looking at it from a relative standpoint/angle....with an improved label and potential improved coverage most are looking forward rather than in the rear view mirror as everyone that has been following have known the biggest obstacles since initial approval...fortunately depending on how you view it, the former administration and their corrupt appointments are gone from the current landscape and the new administration and FDA seems to be sector friendlier regarding speed to approval and getting things that may help individuals health faster to market. So I don't find it difficult to understand the recent optimism regarding the potential corresponding improvements in sales/scripts with the new capitalization and label, along with the further studies. So again, thanks for bringing it up again since I believe it was important this time to respond as normally I would just ignore and move on. As I mentioned in another thread where MR. HOLDEM felt everyone should ignore the SA pieces, sometimes it's better to stop and take the time to help educate the new followers/longs on what was then and where it is now. I know of fellow longs that have friends that tell them they should "sell" and "it's never going to go anywhere" without those individuals knowing one thing about the company or its history....after all we're just labeled as "the blinded MNKD cult" but I like to think a well informed one at that .
|
|
|
Post by blindhog1 on Oct 23, 2017 15:58:51 GMT -5
Side note: MannKind doesn't give up. Got back from my Endo today with an A1C of 6.4 down from 7.3 6 months ago. On the wall in the examining room was a digital billboard (2'x3') that touted numerous treatments for diabetes. I believe the third one in the rotation was AFREZZA. Since my Endo is a prescriber, researcher and user, I shouldn't have been surprised but I was. Nice advertising.
During that same 6 months I've lost 40 lbs. Some time let me tell you about the virtues of wokking for diabetics. Trade in some of your other carbs for rice.
|
|
|
Post by peppy on Oct 23, 2017 16:11:57 GMT -5
Side note: MannKind doesn't give up. Got back from my Endo today with an A1C of 6.4 down from 7.3 6 months ago. On the wall in the examining room was a digital billboard (2'x3') that touted numerous treatments for diabetes. I believe the third one in the rotation was AFREZZA. Since my Endo is a prescriber, researcher and user, I shouldn't have been surprised but I was. Nice advertising.
During that same 6 months I've lost 40 lbs. Some time let me tell you about the virtues of wokking for diabetics. Trade in some of your other carbs for rice.
I made chicken kabobs at my daughters home. chicken marinated in 1 tablespoon salad dressing 1 tablespoon apple cider vinegar. portabella mushroom, onion, red pepper. served with wild rice cooked in chicken broth and 1 tablespoon garlic. here is to eating well, blindhog.
|
|
|
Post by mango on Oct 23, 2017 16:19:57 GMT -5
Got back from my Endo today with an A1C of 6.4 down from 7.3 6 months ago. On the wall in the examining room was a digital billboard (2'x3') that touted numerous treatments for diabetes. I believe the third one in the rotation was AFREZZA. Since my Endo is a prescriber, researcher and user, I shouldn't have been surprised but I was. Nice advertising.
During that same 6 months I've lost 40 lbs. Some time let me tell you about the virtues of wokking for diabetics. Trade in some of your other carbs for rice.
I made chicken kabobs at my daughters home. chicken marinated in 1 tablespoon salad dressing 1 tablespoon apple cider vinegar. portabella mushroom, onion, red pepper. served with wild rice cooked in chicken broth and 1 tablespoon garlic. here is to eating well, blindhog.
What kind of salad dressing?
|
|
|
Post by mnkdfann on Oct 23, 2017 16:37:38 GMT -5
FWIW, that's not actually true. Orlon might be perpetually negative and maybe even a MNKD short, but his first posts were in 2013 and were not about ORMP. His 2014 post about ORMP was just acknowledging that an analyst / blogger who covered both ORMP and MNKD had just made a good call at the time, contrary to what orlon's expectations were. But, really, why harp on orlon anyway when a majority of the posters here do the same thing (new threads with basically the same perpetually sunny scenarios). His first post on ORMP was with it being at it's peak, it was pretty much all downhill from there regarding their share price (albeit off the lows but still a far cry from the peak), that was my point....he was referencing/bringing up a company and someone that was critical of MNKD (De Stefano), my point was where have they been and where are they now? when he brought them up the price was approx $29/sh and currently sitting between $10-$11/sh. Regarding threads, there are those that are creatures of habit/lazy on both sides of the coin starting threads whether positive or negative...but when one says the same thing repetitively on one subject (which btw everyone both long and short know already regarding scripts/sales) it gets redundant. But hey thanks for checking up on this as someone that is just "hanging around" as you stated: 10 million share stock offering Oct 11, 2017 at 11:18am afrezzamiracle likes this Quote like Post Options Post by mnkdfann on Oct 11, 2017 at 11:18am One of my investments is MU. I've no MNKD shares presently, but I obviously follow it.
Last night both MNKD and MU announced share offerings. It is interesting how the corresponding (especially retail) investor groups viewed the offerings. MU investors were outraged, predicted a massive hit in MU's share price today. MNKD investors (judging from most comments here) were pleased as punch and predicting a restless night for, and the quick demise, of shorts. I found the different perspectives interesting, and funny (not in the humorous sense) how things turn out (MU is doing fine, and just might hit another 52-week high today). Full disclosure. Since that old Oct 11 post of mine you quoted (and why you bothered to do so is hard to figure, unless you were throwing shade) I did purchase shares in MNKD. With hindsight, I wish I had not done so. But the perma-pumpers with their always sunny scenarios sucked me in. Thankfully, mine was a small investment.
|
|
|
Post by peppy on Oct 23, 2017 16:41:01 GMT -5
I made chicken kabobs at my daughters home. chicken marinated in 1 tablespoon salad dressing 1 tablespoon apple cider vinegar. portabella mushroom, onion, red pepper. served with wild rice cooked in chicken broth and 1 tablespoon garlic. here is to eating well, blindhog.
What kind of salad dressing? the secret sauce, I used smokehouse cider dressing. limited to one tablespoon. the ingredient list, canola oil, sugar, apple cider vinegar.
“When I'm good, I'm very good, but when I'm bad, I'm better. ”
|
|
|
Post by compound26 on Oct 23, 2017 17:03:32 GMT -5
Side note: MannKind doesn't give up. Got back from my Endo today with an A1C of 6.4 down from 7.3 6 months ago. On the wall in the examining room was a digital billboard (2'x3') that touted numerous treatments for diabetes. I believe the third one in the rotation was AFREZZA. Since my Endo is a prescriber, researcher and user, I shouldn't have been surprised but I was. Nice advertising.
During that same 6 months I've lost 40 lbs. Some time let me tell you about the virtues of wokking for diabetics. Trade in some of your other carbs for rice.
blindhog1 Welcome back! WOW. This is unbelievable. Don't tell me you are going from 800 lbs to 760 lbs. Please consider also sharing this great success story on Twitter. I guess there a lot PWDs who would like to shed a few pounds.
|
|
|
Post by joeypotsandpans on Oct 23, 2017 17:33:18 GMT -5
His first post on ORMP was with it being at it's peak, it was pretty much all downhill from there regarding their share price (albeit off the lows but still a far cry from the peak), that was my point....he was referencing/bringing up a company and someone that was critical of MNKD (De Stefano), my point was where have they been and where are they now? when he brought them up the price was approx $29/sh and currently sitting between $10-$11/sh. Regarding threads, there are those that are creatures of habit/lazy on both sides of the coin starting threads whether positive or negative...but when one says the same thing repetitively on one subject (which btw everyone both long and short know already regarding scripts/sales) it gets redundant. But hey thanks for checking up on this as someone that is just "hanging around" as you stated: 10 million share stock offering Oct 11, 2017 at 11:18am afrezzamiracle likes this Quote like Post Options Post by mnkdfann on Oct 11, 2017 at 11:18am One of my investments is MU. I've no MNKD shares presently, but I obviously follow it.
Last night both MNKD and MU announced share offerings. It is interesting how the corresponding (especially retail) investor groups viewed the offerings. MU investors were outraged, predicted a massive hit in MU's share price today. MNKD investors (judging from most comments here) were pleased as punch and predicting a restless night for, and the quick demise, of shorts. I found the different perspectives interesting, and funny (not in the humorous sense) how things turn out (MU is doing fine, and just might hit another 52-week high today). Full disclosure. Since that old Oct 11 post of mine you quoted (and why you bothered to do so is hard to figure, unless you were throwing shade) I did purchase shares in MNKD. With hindsight, I wish I had not done so. But the perma-pumpers with their always sunny scenarios sucked me in. Thankfully, mine was a small investment. In hindsight we all could say we wish we bought lower on various investments at one time or another, also you should never just blindly follow what you term as the "perma-pumpers". I take it from that statement that you're fairly young for two reasons first one is you purchased shares in a company very recent and already have "second" thoughts (pun intended) and secondly, you followed and didn't necessarily do your due diligence at which point had you done so you may still be comfortable with the shares you purchased. I bought AGEN today at $4.49 which was a price I was comfortable with and still am, I saw the pre-market action and decided to look at the chart to see where the high was on the previous day it traded and dropped it a couple of pennies. It got filled, and after the news of their approval along with their pipeline I was happy to fill at that price and start a position. Sure I could have gotten it lower but then again it's not so much where I started but where I finish. Btw, AGEN has only an 11% short interest lol so I guess I get to have fun with the same anti-biotech breed, especially with their recent mixed shelf registration ($250M), sincerely wish you the BOL going forward!
|
|
|
Post by blindhog1 on Oct 23, 2017 18:01:16 GMT -5
Got back from my Endo today with an A1C of 6.4 down from 7.3 6 months ago. On the wall in the examining room was a digital billboard (2'x3') that touted numerous treatments for diabetes. I believe the third one in the rotation was AFREZZA. Since my Endo is a prescriber, researcher and user, I shouldn't have been surprised but I was. Nice advertising.
During that same 6 months I've lost 40 lbs. Some time let me tell you about the virtues of wokking for diabetics. Trade in some of your other carbs for rice.
blindhog1 Welcome back! WOW. This is unbelievable. Don't tell me you are going from 800 lbs to 760 lbs. Please consider also sharing this great success story on Twitter. I guess there a lot PWDs who would like to shed a few pounds. compound26 today in the waiting room I surveyed the other patients. About a dozen. Everyone of them was me before I decided to lose a few pounds. BMI in the regions of obese. It's not like they are all gorging on Mellomars, just that they had become accustomed to their body size even though every piece of literature is telling them to lose some weight to control the diabetes. It's not any success story, it's common sense.
|
|
|
Post by mnkdfann on Oct 23, 2017 18:10:44 GMT -5
In hindsight we all could say we wish we bought lower on various investments at one time or another, also you should never just blindly follow what you term as the "perma-pumpers". I take it from that statement that you're fairly young for two reasons first one is you purchased shares in a company very recent and already have "second" thoughts (pun intended) and secondly, you followed and didn't necessarily do your due diligence at which point had you done so you may still be comfortable with the shares you purchased. You'd be mistaken about my age. But my MU investment did so well, that I was willing to make a very SMALL investment in MNKD, with the house's 'mad money' as it were.
|
|
|
Post by orlon on Oct 23, 2017 18:15:10 GMT -5
Okay Joey etc, let's put this discussion to rest: First, my post on Jan 7, 2014, simply stated the de Stephano may have right on ORMP as the pps jumped signicantly w/o any trial results, but simply acceptance by Israel and Australia, while MNKD barely moved the needle with good trial results. Nothing about buying selling, nothing about prices etc! I suggest you look it up and read it. Second, my perceived negativity is in response to the overly optimistic posts, the last was when the pps was over $6.00 and suddenly talk of $125.00 shows up. I am not short on this stock and take issue with those who lend shares to short sellers who in turn drive the price down. I take the product seriously as I have several members of family who are diabetics...one in Scotland and on a pump, therefore I hope like hell this product succeeds and is distributed worldwide. I would normally say I' m sorry for offending your sensibilies, but the would be somewhat disingenuous of me. Hopefully we'll hear no more of this Orlon guy talk and stick to the product.
|
|
|
Post by joeypotsandpans on Oct 23, 2017 19:06:15 GMT -5
Okay Joey etc, let's put this discussion to rest: First, my post on Jan 7, 2014, simply stated the de Stephano may have right on ORMP as the pps jumped signicantly w/o any trial results, but simply acceptance by Israel and Australia, while MNKD barely moved the needle with good trial results. Nothing about buying selling, nothing about prices etc! I suggest you look it up and read it. Second, my perceived negativity is in response to the overly optimistic posts, the last was when the pps was over $6.00 and suddenly talk of $125.00 shows up. I am not short on this stock and take issue with those who lend shares to short sellers who in turn drive the price down. I take the product seriously as I have several members of family who are diabetics...one in Scotland and on a pump, therefore I hope like hell this product succeeds and is distributed worldwide. I would normally say I' m sorry for offending your sensibilies, but the would be somewhat disingenuous of me. Hopefully we'll hear no more of this Orlon guy talk and stick to the product. Appreciate the feedback and honesty, actually earlier you said you hit a sore spot and I thought about that statement and indirectly it is a sore spot with me that you mention the script numbers or lack thereof and there are those like myself that are frustrated we received a script and it ends up not being covered and in turn a non refill as well. Regarding the "overly optimistic" posts I would imagine those are in response to the overly pessimistic ones that preached the company would be non-existent by now. Btw, from what I understand only dead people can't dream BOL to you and the family, that is definitely something we can agree on
|
|
|
Post by mango on Oct 23, 2017 22:15:18 GMT -5
I think what joeypotsandpans is saying is that he/she has had it with the insurance companies, and the burden he/she is having to go through just with trying to get the insulin he/she wants is a daily struggle and shouldn't be. I'm just guessing there, but I'll add some of my thinking to this. Insulin is a natural hormone and is required in order for a human to carry out many physiological processes. A human will not survive for very long without insulin. I think any person has every right to be pissed in this scenario. No one should be hindered by a health insurance company, PBM and/or ignorant/corrupt Endo and the like from receiving the medicine he or she needs, especially when it has been approved by the FDA. That's the government's seal of approval right there. So, what's the problem? And in this case it appears joey was prescribed Afrezza. If you're prescribed Afrezza you should receive Afrezza. Insulin isn't an elective therapy in this case. So I think what joey is getting at is he/she is tired of the insurance companies and also tired of the negative people that talk negatively about MannKind and Afrezza, because MannKind developed and manufactures this insulin and joey wishes to use it for his/her health. Health is personal and a natural process for all living organisms on Earth. Here we have a health insurance company hindering joey of a hormone required for maintaining health. Sales are not what is important. Making sure people like joey receive Afrezza when prescribed Afrezza is what is important. It's one of a handful of FDA approved prandial insulins, and the world's only inhaled insulin. Health insurance companies shouldn't be hindering someone from receiving a medicine to restore and maintain health. There's clearly a problem here and it isn't with MannKind. When it come to insulin, all insulins should be covered by every company that is going to set up shop and claim to be a health insurance company, collect money from people, and regulate coverage on medicines for a human. Something required by the body, such as insulin, shouldn't be up for debate. This goes for all insulins that are FDA approved, IMO. The FDA needs to reform how drugs are viewed and considered by these companies and should be demanding better ethics of these health insurance companies. They should be fined every time a lifesaving drug is denied coverage and should be investigated for possible corruption. We aren't talking whether or not a health insurance company will cover something ridiculous here, we are literally just talking about insulin. The government shouldn't be going around stamping their seal of approval on lots of things, but here we have the safest insulin in the world that people simply cannot get because of a health insurance company. I think what the problem is should be pretty obvious.
|
|
|
Post by zoller35 on Oct 24, 2017 11:26:21 GMT -5
I've been here since $10 pre-split, I want them to be deterred by the stock price.
They had the same flipping problem back with Hakan, update the company info - if you can't even manage that, what else are you not doing?
|
|
|
Post by dreamboatcruise on Oct 24, 2017 11:31:16 GMT -5
This management team is completely inept. Share price is like filling a bucket full of holes because they are just doing the same thing (which already didn't work the first time around) over and over again. Not to mention, how long has Mike been CEO and they haven't even changed the company bio on google!? According to google it's still Matt P. Unreal. Really? FYI, the management is not, and unfortunate, cannot be either, be responsible for the day to day fluctuations of the share price. From my point of view, the net effects: 1. >$57m in the bank. 2. Finance term changes, extended run way at least to eoy 2018, some actually believe we will become cash flow positive before cash ran out now. 3. Sales are trending up, pending exponential explosion. Here is the hope. 4. Internatinal deals underway. Even the stocks, at $3.25, is more than 60% higher than just a month ago. I know of your frustration and that is what you are talking about. Just want to add some perspectives. If u r an investor instead of a trader, you should be super happy with the management because they are not deterred by the daily stock price. This would seem highly questionable given 1) current rev growth and math and 2) statement from management saying something to the effect of this being a step in their recapitalization efforts. Seems management is expecting to need further infusion before cash flow positive, though I suppose anyone here is free to be even more optimistic than management, but... it seems we are already tracking below where we would meet the low end of management's guidance for 2H2017
|
|